Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBR-652 in HIV-1 infection
NCT01092104Phase 2Completed
- Sponsor
- Tobira Therapeutics
- Start
- Feb 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cenicriviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tobira Therapeutics. Started Feb 2009; status: completed.
02
Drugs
cenicriviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01092104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092104.